5-161685998-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1
The ENST00000274545.10(GABRA6):c.9G>A(p.Ser3=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.23 in 1,611,882 control chromosomes in the GnomAD database, including 46,739 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.18 ( 3113 hom., cov: 32)
Exomes 𝑓: 0.24 ( 43626 hom. )
Consequence
GABRA6
ENST00000274545.10 synonymous
ENST00000274545.10 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.855
Genes affected
GABRA6 (HGNC:4080): (gamma-aminobutyric acid type A receptor subunit alpha6) GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 5-161685998-G-A is Benign according to our data. Variant chr5-161685998-G-A is described in ClinVar as [Benign]. Clinvar id is 1169909.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.855 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.253 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRA6 | NM_000811.3 | c.9G>A | p.Ser3= | synonymous_variant | 1/9 | ENST00000274545.10 | NP_000802.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRA6 | ENST00000274545.10 | c.9G>A | p.Ser3= | synonymous_variant | 1/9 | 1 | NM_000811.3 | ENSP00000274545 | P1 | |
GABRA6 | ENST00000523217.5 | c.9G>A | p.Ser3= | synonymous_variant | 1/9 | 5 | ENSP00000430527 | |||
GABRA6 | ENST00000522269.5 | n.352-232G>A | intron_variant, non_coding_transcript_variant | 4 | ||||||
GABRA6 | ENST00000518888.1 | downstream_gene_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.177 AC: 26950AN: 152006Hom.: 3113 Cov.: 32
GnomAD3 genomes
AF:
AC:
26950
AN:
152006
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.190 AC: 47863AN: 251412Hom.: 5443 AF XY: 0.192 AC XY: 26113AN XY: 135876
GnomAD3 exomes
AF:
AC:
47863
AN:
251412
Hom.:
AF XY:
AC XY:
26113
AN XY:
135876
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.235 AC: 343052AN: 1459758Hom.: 43626 Cov.: 31 AF XY: 0.232 AC XY: 168206AN XY: 726248
GnomAD4 exome
AF:
AC:
343052
AN:
1459758
Hom.:
Cov.:
31
AF XY:
AC XY:
168206
AN XY:
726248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.177 AC: 26949AN: 152124Hom.: 3113 Cov.: 32 AF XY: 0.175 AC XY: 12980AN XY: 74352
GnomAD4 genome
AF:
AC:
26949
AN:
152124
Hom.:
Cov.:
32
AF XY:
AC XY:
12980
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
241
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Childhood absence epilepsy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2023 | - - |
GABRA6-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at